At a glance
- Originator Yamanouchi
- Class Antibacterials; Macrolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Staphylococcal infections
Most Recent Events
- 19 Jun 2001 No-Development-Reported for Bacterial infections in Indonesia (unspecified route)
- 19 Jun 2001 No-Development-Reported for Bacterial infections in Japan (unspecified route)
- 19 Jun 2001 No-Development-Reported for Staphylococcal infections in Indonesia (unspecified route)